230 related articles for article (PubMed ID: 21272775)
21. Tranexamic acid versus ɛ-aminocaproic acid: efficacy and safety in paediatric cardiac surgery.
Martin K; Breuer T; Gertler R; Hapfelmeier A; Schreiber C; Lange R; Hess J; Wiesner G
Eur J Cardiothorac Surg; 2011 Jun; 39(6):892-7. PubMed ID: 21115357
[TBL] [Abstract][Full Text] [Related]
22. Putting the record straight on aprotinin as safe and effective: results from a mixed treatment meta-analysis of trials of aprotinin.
Howell N; Senanayake E; Freemantle N; Pagano D
J Thorac Cardiovasc Surg; 2013 Jan; 145(1):234-40. PubMed ID: 22889481
[TBL] [Abstract][Full Text] [Related]
23. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
24. Natural and synthetic antifibrinolytics: inert, poisonous or therapeutic agents?
Hardy JF; Bélisle S
Can J Anaesth; 1997 Sep; 44(9):913-7. PubMed ID: 9305552
[No Abstract] [Full Text] [Related]
25. Antifibrinolytics in cardiac surgery.
Dhir A
Ann Card Anaesth; 2013; 16(2):117-25. PubMed ID: 23545866
[TBL] [Abstract][Full Text] [Related]
26. Current antifibrinolytic therapy for coronary artery revascularization.
Trudell J; McMurdy N
AANA J; 2008 Apr; 76(2):121-4. PubMed ID: 18478817
[TBL] [Abstract][Full Text] [Related]
27. The blood sparing effect and the safety of aprotinin compared to tranexamic acid in paediatric cardiac surgery.
Breuer T; Martin K; Wilhelm M; Wiesner G; Schreiber C; Hess J; Lange R; Tassani P
Eur J Cardiothorac Surg; 2009 Jan; 35(1):167-71; author reply 171. PubMed ID: 19027313
[TBL] [Abstract][Full Text] [Related]
28. Comparison of tranexamic acid with aprotinin in pediatric cardiac surgery.
Chauhan S
Ann Card Anaesth; 2015; 18(1):27-8. PubMed ID: 25566707
[No Abstract] [Full Text] [Related]
29. [The efficacy and safety of tranexamic acid and epsilon-aminocapronic acid in cardiac surgery under extracorporeal circulation].
Iavorovskiĭ AG; Ziuliaeva TP; Charnaia MA; Morozov IuA; Tolstova IA; Gladysheva VG; Buniatian AA
Anesteziol Reanimatol; 2009; (4):10-5. PubMed ID: 19824410
[TBL] [Abstract][Full Text] [Related]
30. Fibrinolytic inhibitors in off-pump coronary surgery: a prospective, randomized, double-blind TAP study (tranexamic acid, aprotinin, placebo).
Vanek T; Jares M; Fajt R; Straka Z; Jirasek K; Kolesar M; Brucek P; Maly M
Eur J Cardiothorac Surg; 2005 Oct; 28(4):563-8. PubMed ID: 16125959
[TBL] [Abstract][Full Text] [Related]
31. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
32. Risks of harms using antifibrinolytics in cardiac surgery: systematic review and network meta-analysis of randomised and observational studies.
Hutton B; Joseph L; Fergusson D; Mazer CD; Shapiro S; Tinmouth A
BMJ; 2012 Sep; 345():e5798. PubMed ID: 22968722
[TBL] [Abstract][Full Text] [Related]
33. Lessons from aprotinin: is the routine use and inconsistent dosing of tranexamic acid prudent? Meta-analysis of randomised and large matched observational studies.
Ngaage DL; Bland JM
Eur J Cardiothorac Surg; 2010 Jun; 37(6):1375-83. PubMed ID: 20117944
[TBL] [Abstract][Full Text] [Related]
34. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
35. The use of antifibrinolytic agents in total hip arthroplasty: a meta-analysis.
Gill JB; Rosenstein A
J Arthroplasty; 2006 Sep; 21(6):869-73. PubMed ID: 16950041
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of synthetic antifibrinolytic agents during liver transplantation.
Kang Y
Semin Thromb Hemost; 1993; 19(3):258-61. PubMed ID: 8362255
[No Abstract] [Full Text] [Related]
37. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
[TBL] [Abstract][Full Text] [Related]
38. Antifibrinolytic agents in current anaesthetic practice.
Ortmann E; Besser MW; Klein AA
Br J Anaesth; 2013 Oct; 111(4):549-63. PubMed ID: 23661406
[TBL] [Abstract][Full Text] [Related]
39. Antifibrinolytic therapy with tranexamic acid in pregnancy and postpartum.
Peitsidis P; Kadir RA
Expert Opin Pharmacother; 2011 Mar; 12(4):503-16. PubMed ID: 21294602
[TBL] [Abstract][Full Text] [Related]
40. [Hemostasis and antifibrinolytic therapy in major pediatric surgery].
Schindler E; Hertfelder HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):454-61; quiz 462. PubMed ID: 23929163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
